Pharmaceuticals

2 articles

Helix BioPharma Corp. Announces Fiscal 2026 Year-End Results

TheNewswire 30 Oct 2026

Vancouver, British Columbia – TheNewswire - October 29, 2026 – Helix BioPharma Corp. (TSX: “HBP”, OTC: “HBPCF”, FRANKFURT: “HBP0”) ( “Helix” or the “Company” ), a clinical-stage oncology company developing…

Healthcare

Adaptogenics Appoints Antoun Nabhan as President

TheNewswire 13 Oct 2026

Former executive at Onyx Pharmaceuticals, Raptor Pharmaceuticals and Soleno Therapeutics brings experience across more than $2 billion in healthcare transactions and two Nasdaq IPO processes Vancouver, British Columbia – TheNewswire…

Kraken Restores Spot And Derivatives Trading After One Hour Outage

Coinbase Surge In Q3 Net Income Driven By Derivatives And Prediction Markets

Kraken Restores Trading After One-Hour Outage Disrupts Spot and Derivatives Markets

The CFTC, a US derivatives regulator, expands prediction markets litigation to 10 states

Trezor Hardware Wallets Alert Follows Suspected Implant Report

CFTC Chair Selig Says AI Agents Raise New Questions for Crypto Regulation

Ripple Wins Final OCC Bank Approval as XRP Eyes $1.50

Mastercard Reportedly Praises RLUSD Stablecoin at XRPL Event

Helix BioPharma Corp. Announces Fiscal 2026 Year-End Results

Adaptogenics Appoints Antoun Nabhan as President

Latest

Sections

Latest

Trending

Sections